Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022. Clin Breast Cancer. 2020 04; 20(2):145-151.e2.

View in: PubMed

subject areas

Administration, Oral
Adult
Antineoplastic Combined Chemotherapy Protocols
Brain
Brain Neoplasms
Breast
Breast Neoplasms
Chemotherapy, Adjuvant
Craniotomy
Drug Administration Schedule
Female
Humans
Middle Aged
Neoadjuvant Therapy
Pilot Projects
Quinolines
Receptor, ErbB-2
Tissue Distribution
Treatment Outcome

authors with profiles

Ian F Dunn